Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Net Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/Net Sales(x) 3.334.012.814.430.86

What is the latest EV/Net Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Net Sales ratio of SYNCOM FORMULATIONS (INDIA) is 3.33 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.33
Mar20244.01
Mar20232.81
Mar20224.43
Mar20170.86

How is EV/Net Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Net Sales % Change
Mar2025 3.33
-16.96
Mar2024 4.01
42.70
Mar2023 2.81
-36.57
Mar2022 4.43
415.12
Mar2017 0.86 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Net Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,290.6 Cr 2% 25.4% -19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2%

25.4%

-19.2%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses